Get App

Co-Partners

Associate Partners

SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 21, 14:09
2670.00
81.95 (3.17%)
VOLUME 70,339
LIVE
NSE
May 21, 14:09
2677.85
88.45 (3.42%)
VOLUME 1,652,833
News on Dr Reddys Laboratories
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's to launch 20 products in US in FY20

10.23 pm | 17 May 2019 |  Source: Moneycontrol.com

The company anticipates US FDA approval for generic Nuvaring in the first half of FY20, while the launch of generic Copaxone in the US may get further...

Dr Reddys Labs Standalone March 2019 Net Sales at Rs 2,645.20 crore, up 6.13% Y-o-Y

3.50 pm | 17 May 2019 |  Source: Moneycontrol.com

NULL...

Dr Reddys Labs Consolidated March 2019 Net Sales at Rs 4,029.60 crore, up 13.39% Y-o-Y

3.50 pm | 17 May 2019 |  Source: Moneycontrol.com

NULL...

Dr Reddy’s Q4 net up 44% YoY at Rs 434cr

3.33 pm | 17 May 2019 |  Source: Moneycontrol.com

Revenue rose 14 percent YoY to Rs 4,016.6 crore....

Dr Reddy's Q4 preview: Profit to rise 37% YoY to Rs 413cr; EBITDA margin may touch 23%

9.27 am | 17 May 2019 |  Source: Moneycontrol.com

Narnolia Financial Advisors expects the pharma company to report a net profit of Rs 545 crore as against Rs 500 crore in the last quarter...

Options Trade | An Iron Condor trade in Dr Reddy's Laboratories

8.24 am | 17 May 2019 |  Source: Moneycontrol.com

An Iron Condor trade in Dr Reddys Laboratories ahead of its results to benefit from high implied volatiltiy...

Dr Reddy's launches skin treatment drug in US

2.40 pm | 15 May 2019 |  Source: PTI

The company has launched its product, which is generic version of Merck Sharp & Dohme Corp's Cubicin, after obtaining approval from the US Food an...

Top buy and sell ideas by Mitessh Thakkar, Prakash Gaba for short term 

9.04 am | 26 Apr 2019 |  Source: Moneycontrol.com

Mitessh Thakkar of mitesshthakkar.com recommends buying Dr Reddy's Labs with a stop loss of Rs 2892 and target of Rs 3000 and advises selling Godr...

Dr Reddy's gets approval for anti-platelet drug in China

4.53 pm | 25 Apr 2019 |  Source: PTI

Clopidogrel is an anti-platelet drug that blocks platelets from sticking together and prevents them from forming harmful clots....

Dr Reddy’s Laboratories Q4 PAT seen up 36.9% YoY to Rs. 413.6 cr: Kotak

3.15 pm | 17 Apr 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 7.7 percent Y-o-Y (down 1.1 percent Q-o-Q) to Rs. 3,807.5 crore, according to Kotak....

Dr Reddy’s Laboratories gains on EIR from USFDA

11.24 am | 16 Apr 2019 |  Source: Moneycontrol.com

The share touched its 52-week high Rs 2,875 and 52-week low Rs 1,888 on 04 February, 2019 and 21 May, 2018, respectively....

Stocks in the news: Wipro, Cipla, Prestige Estates, Jet Airways, Polycab India, Deepak Fertilizers

7.42 am | 16 Apr 2019 |  Source: Moneycontrol.com

Jet Airways | Polycab India | Deepak Fertilizers | Cyient | Wipro | Cipla and Prestige Estates are stocks which are in the news today....

Dr Reddy's falls despite ANDA portfolio acquisition in US; Nomura sees 22% upside

12.15 pm | 15 Apr 2019 |  Source: Moneycontrol.com

Japanese brokerage house Nomura said the deal is positive both from a strategic as well as a financial perspective....

Dr Reddy's acquires a portfolio of 42 ANDAs in US

8.39 am | 14 Apr 2019 |  Source: Moneycontrol.com

The acquisition is in line with our stated strategy to significantly enhance our portfolio in our chosen growth markets, Dr Reddy's Laboratories C...

Dr. Reddy’s Laboratories Q4 PAT seen up 88.4% YoY to Rs. 512.7 cr: Prabhudas Lilladher

1.00 pm | 12 Apr 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 12.4 percent Y-o-Y (up 3.4 percent Q-o-Q) to Rs. 3,994.3 crore, according to Prabhudas Lilladher....

Hold Dr Reddy’s Laboratories; target of Rs 2870: ICICI Direct

4.45 pm | 19 Feb 2019 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Dr Reddy’s Laboratories with a target price of Rs 2870 in its research report dated February 04, 2019....

Dr Reddys Labs Consolidated December 2018 Net Sales at Rs 3,864.60 crore, up 0.8% Y-o-Y

6.38 pm | 01 Feb 2019 |  Source: Moneycontrol.com

NULL...

Dr Reddys Labs Standalone December 2018 Net Sales at Rs 2,731.70 crore, up 8.27% Y-o-Y

6.36 pm | 01 Feb 2019 |  Source: Moneycontrol.com

NULL...

Dr Reddy's Labs Q3 profit jumps 45% to Rs 485 cr, US business falls 8%

3.05 pm | 01 Feb 2019 |  Source: Moneycontrol.com

Revenue from operations increased 1 percent year-on-year to Rs 3,850 crore in quarter ended December 2018 as the growth in India, Europe and Emerging ...

Dr Reddy's Q3 preview: Analysts expect strong profit but moderate revenue growth

8.30 am | 01 Feb 2019 |  Source: Moneycontrol.com

Kotak, which sees 2.4% growth in topline, also forecasts 12% YoY growth for India...

1 2 3
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.